Cipla CEO On Lung Leadership Beyond Asthma, AMR Plans
CEO Vohra Talks Strategy With Scrip
Executive Summary
CEO Umang Vohra outlines where Cipla is heading in its priority areas of lung route therapies and antimicrobial resistance. He also weighs in on the simmering issue of intellectual property waivers for COVID-19 vaccines.